Activation of the renin-angiotensin-aldosterone system (RAS)and subsequent elevations in angiotensin II and aldosterone,as seen in the metabolic syndrome, also contribute to altered insulin/IGF-1signaling pathways and reactive oxygen species formation toinduce endothelial dysfunction and cardiovascular disease. The gene discussed is INS; the disease is metabolic syndrome.